MARIA DE LOS DOLORES PEREZ ALENZA

Full Professor

Universidad Complutense de Madrid

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Maria de los Dolores Perez Alenza is a Full Professor at Complutense University of Madrid, Spain. Her research focuses on canine inflammatory mammary cancer, immunotherapy, and hormonal parallels between canine and human breast cancer. Recent publications emphasize novel therapeutic approaches and histopathological insights into canine mammary tumors, contributing significantly to the field of veterinary oncology.

Articles (12)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Johannes vom Berg

University of Zurich

SWITZERLAND

View details

Natalia Sevane

SPAIN

View details

Daniel Alonso-Miguel

Asistant Professor

Universidad Complutense de Madrid

SPAIN

View details

Gustavo Ortiz-Díez

Universidad Complutense de Madrid

SPAIN

View details

Ryane Englar

Associate Professor

University of Arizona

UNITED STATES

View details

Laura Peña

Full Professor

Universidad Complutense de Madrid

SPAIN

View details

Felisbina Queiroga

Prof. Associado com Agregação

Universidade de Trás-os-Montes e Alto Douro

PORTUGAL

View details

María Suárez-Redondo

Universidad Complutense de Madrid

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

MARIA DE LOS DOLORES PEREZ ALENZA

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Induces Local and Systemic Antitumor Efficacy in Canine Mammary Cancer Patients

Transcriptomics of Canine Inflammatory Mammary Cancer Treated with Empty Cowpea Mosaic Virus Implicates Neutrophils in Anti-Tumor Immunity

Cell adhesion molecules E-cadherin and CADM1 are differently expressed in canine inflammatory mammary cancer

Epitheliosis is a histopathological finding associated with malignancy and poor prognosis in dogs with mammary tumors

Hormonal Homologies between Canine Mammary Cancer and Human Breast Cancer in a Series of Cases

Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase‐2 inhibitor and toceranib phosphate

Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer

Survival of dogs with pituitary-dependent hyperadrenocorticism treated twice daily with low doses of trilostane.

Use of Deoxycorticosterone Pivalate by Veterinarians: A Western European Survey.

From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review

Changes in systolic blood pressure in dogs with pituitary dependent hyperadrenocorticism during the first year of trilostane treatment

Evaluation of palliative therapy, alone or in combination with toceranib phosphate, in dogs diagnosed with metastatic or recurrent beta-cell neoplasia

Collaborators (8)

Johannes vom Berg

Natalia Sevane

Daniel Alonso-Miguel

Gustavo Ortiz-Díez

Ryane Englar

Laura Peña

Felisbina Queiroga

María Suárez-Redondo

Make your next move.